Tag results:
lymphocytes
Cell Therapy News
Exploiting T Cell Signaling to Optimize Engineered T Cell Therapies
[Trends in Cancer] The authors synthesize recent findings on T cell antigen receptor and CAR signaling and highlights the potential strategies of T cell engineering by signaling refinement.
Human Immunology News
Type I Interferon Activates MHC Class I-dressed CD11b+ Conventional Dendritic Cells to Promote Protective Anti-Tumor CD8+ T Cell Immunity
[Immunity] Transcriptional profiling of intra-tumoral dendritic cells (DCs) within regressor tumors revealed an activation state of CD11b+ conventional DCs characterized by expression of interferon-stimulated genes.
Human Immunology News
B7-H3 Suppresses Anti-Tumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
[Cancer Immunology Research] Transcriptome analysis revealed that B7-H3 was highly expressed in PD-L1-low, non-immunoreactive high-grade serous ovarian cancer tumors, and its expression negatively correlated with an IFNγ signature, which reflected the tumor immune-reactivity.
Immunology of Infectious Disease News
Delayed Antiretroviral Therapy in HIV-Infected Individuals Leads to Irreversible Depletion of Skin- and Mucosa-Resident Memory T Cells
[Immunity] Scientists found that skin CD4+ tissue-resident memory T cells were depleted after HIV infection and replenished only upon early antiretroviral therapy initiation.
Organoid News
Empirical Identification and Validation of Tumor-Targeting T Cell Receptors from Circulation Using Autologous Pancreatic Tumor Organoids
[Journal For Immunotherapy of Cancer] Autologous tumor organoids were stimulated with T cells from the patients’ peripheral blood for two weeks to generate the organoid-primed T cells.
Dermal Cell News
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
[Cancer Research] Emerging evidence indicates B cell activating factor (BAFF) to be an important cytokine for anti-tumor immunity. The authors generated a BAFF-overexpressing B16.F10 melanoma cell model and found that BAFF-expressing tumors grew more slowly in vivo than control tumors.